KRAS and cancer: Paired analyses of the five isogenic cancer cell line doublets with modulated Kras (LLC, MC38, and AE17 cells expressing shC versus shKras and PANO2 and B16F10 cells expressing pC versus pKrasG12C) identified another 3432 Kras-responsive transcripts.